Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perifosine in Relapsed or Refractory CLL/SLL
NCT00873457Phase 2Completed
- Start
- Aug 2009
- Primary completion
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of perifosine in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL). Started Aug 2009; status: completed.
02
Drugs
perifosine
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT00873457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00873457.